Intellia lines up deal with Renegeron and a stock offering
Saturday, April 16, 2016 - 03:12
in Biology & Nature
Developer of CRISPR/Cas9 therapies finds a partner and looks to future investors to support its pipeline
Updated by artificial intelligence Thu, 13 Mar 2025, 3:35:01 UTC Learn more
- Tell your friends
- Get science news via